Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2081 studies found for:    diabetes | NIH
Show Display Options
Rank Status Study
1 Active, not recruiting Look AHEAD: Action for Health in Diabetes
Conditions: Diabetes;   Myocardial Infarction;   Stroke;   Kidney Diseases;   Bone Diseases;   Dyslipidemia
Interventions: Behavioral: Lifestyle Intervention;   Behavioral: Diabetes Support and Education
2 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
3 Unknown  Diabetes Prevention Program Outcomes Study
Condition: Diabetes Mellitus
Interventions: Behavioral: Group Lifestyle;   Drug: Metformin;   Behavioral: Boost Lifestyle
4 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
Intervention:
5 Active, not recruiting ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG);   Drug: Granulocyte colony stimulating factor (GCSF);   Drug: Placebo (for ATG);   Drug: Placebo (for GCSF)
6 Completed
Has Results
Rituximab in New Onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Anti-CD20 (rituximab)
7 Active, not recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
8 Completed Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Condition: Diabetes Mellitus, Type 1
Interventions: Procedure: Mixed Meal Tolerance Test;   Procedure: Glucagon Stimulation Test
9 Completed
Has Results
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: CTLA-4 Ig;   Other: Placebo
10 Completed
Has Results
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Mycophenolate mofeteil (MMF);   Drug: Daclizumab (DZB);   Drug: Placebo control for Mycophenolate mofeteil (MMF);   Drug: Placebo control for Daclizumab (DZB)
11 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
12 Completed Effects of Recombinant Human Glutamic Acid Decarboxylase . . .
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: GAD-Alum;   Drug: Aluminum hydroxide
13 Completed The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Crystallized human recombinant insulin
14 Active, not recruiting TEDDY - The Environmental Determinants of Diabetes in the Young
Condition: Type 1 Diabetes Mellitus
Intervention:
15 Terminated
Has Results
Inducing Remission in Type 1 Diabetes With Alefacept
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Biological: Alefacept;   Drug: Placebo
16 Enrolling by invitation TODAY2 Phase 2 Follow-up
Condition: Type 2 Diabetes
Intervention: Other: TODAY cohort
17 Completed Diabetes Prevention Program
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Glucose Intolerance
Intervention: Behavioral: Intensive lifestyle
18 Active, not recruiting Reducing Stress in Adolescents and Young Adults With T1D to Improve Diabetes Care
Condition: Type 1 Diabetes
Interventions: Behavioral: Cognitive Behavioral Therapy;   Behavioral: Mindfulness Based Stress Reduction;   Behavioral: Diabetes Support and Education
19 Completed Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control
Conditions: Diabetes;   Diabetic Retinopathy
Intervention: Behavioral: Diabetes Education
20 Unknown  Parental Management of Young Children's Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Behavioral: Parental Support;   Behavioral: Diabetes Education

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years